41L Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Laboratorios Farmaceuticos ROVI SA

Watchlist Manager

Watchlist

Price: 62.8 EUR Market Closed

Market Cap: €3.2B

L	Laboratorios Farmaceuticos ROVI SA XBER:41L	ES
	SK Hynix Inc NASDAQ:SKHY	KR
	Drecom Co Ltd TSE:3793	JP
B	Broadstone Net Lease Inc F:62XA	US
S	SSI Group Inc XPHS:SSI	PH
C	Clearway Energy Inc F:NY4B	US
S	Shake Shack Inc SWB:9SH	US
	Compania de Distribucion Integral Logista Holdings SA F:5CI	ES
G	Global Water Resources Inc TSX:GWR	US

Profitability Summary

Laboratorios Farmaceuticos ROVI SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

65%

Strong 3Y Average Gross Margin

62%

Gross Margin is Increasing

62% > 65%

Healthy Operating Margin

25%

Sustainable 3Y Average Operating Margin

26%

Declining Operating Margin

29% > 25%

Healthy Net Margin

19%

Sustainable 3Y Average Net Margin

20%

Declining Net Margin

23% > 19%

Exceptional Free Cash Flow Margin

16%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

5% > 16%

Positive ROE

23%

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

28%

Declining ROIC

46% > 19%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.